Tysabri May Be Option for Kids with MS (CME/CE)

(MedPage Today) -- Off-label treatment with natalizumab (Tysabri) for 20 children with severe multiple sclerosis reduced relapses and brain lesions seen on MRI scans, a retrospective analysis found.
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news